AMANDA PETERS: Open Payments
NPI 1093265266 · JEFFERSON CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,729 in 86 payments from 15 companies in 2025. Trend: 2023 $923 · 2024 $1,354 · 2025 $1,729
Food & beverage: $1,630Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 20 | $584 |
| ABBVIE INC. | 25 | $309 |
| Galderma Laboratories, L.P. | 9 | $161 |
| Novartis Pharmaceuticals Corporation | 5 | $124 |
| Regeneron Healthcare Solutions, Inc. | 5 | $113 |
| UCB, Inc. | 4 | $101 |
| Incyte Corporation | 3 | $72 |
| Amgen Inc. | 4 | $71 |
| Lilly USA, LLC | 4 | $70 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
Products named: TREMFYA, SKYRIZI, NEMLUVIO, DUPIXENT, RINVOQ, Bimzelx, OPZELURA, TALTZ.
Industry payments across MO — which companies pay providers there.
